Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Hearing Loss · Head and Neck Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Winship Cancer Institute at Emory University, Atlanta, Georgia, United States
University of Maryland Medical Center, Baltimore, Maryland, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · prpl@cc.nih.gov · 800-411-1222Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor, Rochester, New York, United States
Inova Schar Cancer Center, Fairfax, Virginia, United States
Study leads
Lisa L Cunningham, Ph.D.
Principal Investigator
National Institute on Deafness and Other Communication Disorders (NIDCD)